drugset / Trial / NCT00082173
Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Current treatment of tuberculosis (TB) requires patients to take four drugs for 8 weeks and then two drugs for 4 months. New drug regimens that are shorter and effective against drug-resistant TB are needed. This study will evaluate whether using the drug moxifloxacin (MOX) in place of ethambutol (EMB) during the first 8 weeks of treatment will effectively treat TB.
Timeline
- Start
- 2004-10
- Primary completion
- 2007-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 400 mg | — |